Evaluation of the Implementation of the Response Assessment in Neuro-Oncology Criteria in the HERBY Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas [PEDIATRICS]
CONCLUSIONS:
The addition of multimodal imaging to the response criteria modified the assessment in a small number of cases, determining progression earlier than structural imaging alone. Increased target lesion diameter, accounting for a large proportion of reading time, was never the only reason to designate disease progression.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Rodriguez, D., Chambers, T., Warmuth-Metz, M., Aliaga, E. S., Warren, D., Calmon, R., Hargrave, D., Garcia, J., Vassal, G., Grill, J., Zahlmann, G., Morgan, P. S., Jaspan, T. Tags: PEDIATRICS Source Type: research
More News: Avastin | Brain | Brain Tumor | Cancer & Oncology | Glioma | Neurology | Pediatrics | Perfusion | PET Scan | Radiation Therapy | Radiology | Study | Temodar